64 participants
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-08-28
- Start Date:
- 2024-05-06
- Completion:
- 2029-12-31
Conditions
- Neuroblastoma
- GD2 Antibody (Naxitamab)
Interventions
- DRUG
No Results Yet